ENTRY       D08044                      Drug
NAME        Hydralazine (INN);
            Hidral (TN)
FORMULA     C8H8N4
EXACT_MASS  160.0749
MOL_WEIGHT  160.1759
CLASS       Cardiovascular agent
             DG03231  Antihypertensive
             DG02046  Hydrazinophthalazine derivative
            Metabolizing enzyme substrate
             DG02928  NAT substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      Same as: C07040
            ATC code: C02DB02
            Chemical structure group: DG00261
            Product (DG00261): D01302<JP/US>
EFFICACY    Antihypertensive, Vasodilator (peripheric)
COMMENT     Hydrazinophthalazine derivative
TARGET      AOC3 [HSA:8639] [KO:K00276]
METABOLISM  Enzyme: NAT [HSA:9 10]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C02 ANTIHYPERTENSIVES
               C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
                C02DB Hydrazinophthalazine derivatives
                 C02DB02 Hydralazine
                  D08044  Hydralazine (INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG03231  Antihypertensive
               DG00261  Hydralazine
                D08044  Hydralazine
              DG02046  Hydrazinophthalazine derivative
               DG00261  Hydralazine
                D08044  Hydralazine
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00261  Hydralazine
                D08044  Hydralazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00261  Hydralazine
                D08044  Hydralazine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                AOC3
                 D08044  Hydralazine (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08044
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG03231  Antihypertensive
               DG00261  Hydralazine
              DG02046  Hydrazinophthalazine derivative
               DG00261  Hydralazine
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00261  Hydralazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00261  Hydralazine
DBLINKS     CAS: 86-54-4
            PubChem: 96024737
            ChEBI: 5775
            PDB-CCD: HLZ
            LigandBox: D08044
            NIKKAJI: J4.262E
ATOM        12
            1   C8y C    24.1500  -18.2700
            2   C8y C    24.1500  -19.6700
            3   C8y C    25.3400  -17.6400
            4   C8x C    22.8900  -17.5700
            5   C8x C    25.3400  -20.3700
            6   C8x C    22.8900  -20.3700
            7   N4x N    26.5300  -18.3400
            8   N2b N    25.3400  -16.2400
            9   C8x C    21.7000  -18.2700
            10  N5x N    26.5300  -19.7400
            11  C8x C    21.7000  -19.6700
            12  N1a N    26.6000  -15.5400
BOND        13
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 2
            9     5  10 2
            10    6  11 2
            11    8  12 1
            12    7  10 1
            13    9  11 1
///
